Risk for Severe COVID-19 Low in Patients With Psoriatic Disease
Researchers reported on the severity of COVID-19 outcomes in patients with psoriatic disease, using data from the WARCOV study.
Psoriasis
Treatment Persistence With IL-17 vs TNF Inhibitors in Psoriasis and Psoriatic Arthritis
The long-term persistence of various biologic agents in treating psoriasis and psoriatic arthritis are investigated.
Why Connections Between Immune-Mediated Diseases and Therapeutic Areas Matter
Lloyd S. Miller, MD, PhD, writes about understanding the overlapping immune pathways between psoriasis and psoriatic arthritis that may be useful to develop treatment plans for patients with these conditions.
Sleep Disturbances Are More Common in Psoriatic Arthritis vs Psoriasis
Researchers sought to determine the prevalence of sleep disturbances among patients with psoriatic arthritis vs those with psoriasis and healthy individuals.
Cardiac Troponin I Levels Linked to Atherosclerosis in Psoriatic Disease
Investigators sought to determine whether cTnI and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) were associated with carotid plaque burden and CV events independent of the Framingham Risk Score (FRS).
Multidisciplinary Perspectives on Pandemic-Era Telemedicine for Psoriatic Arthritis
Rheumatologist Steven Vlad, MD, and dermatologist David Rosmarin, MD, discuss the various aspects of telemedicine in relation to providing care to patients with psoriasis and psoriatic arthritis during and after the COVID-19 pandemic.
Specialist-Led Model of Care Improves CVD Prevention in Patients With Psoriatic Disease
Dermatologists and patients with psoriatic disease have a positive view of a specialist-led model of care to improve cardiovascular disease prevention.
How Effective Is Risankizumab for Fingernail Psoriasis Among Patients With PsA?
The effectiveness of risankizumab (RZB) in treating fingernail psoriasis in patients with psoriatic arthritis is reported.
Lipid Profiles Differ Between Patients With Psoriasis and Psoriatic Arthritis
The effects of methotrexate (MTX) on lipid profiles in patients with psoriasis with (PsA) and without arthritis (PsO) are assessed.
Novel Predictive Model Evaluates Risk for Psoriatic Arthritis in Patients With Plaque Psoriasis
Researchers developed a novel prediction model to evaluate the risk for psoriatic arthritis in plaque psoriasis, using available patient characteristics and clinical manifestations.
- Loading...
Loading...
Next post in News
Loading... 
Loading...